LONDON (ShareCast) - (Sharecast News) - Shares in medical device company Belluscura headed south early on Tuesday as it withdrew FY guidance in a statement regarding the potential impact of the imposition of tariffs on imports to the United States announced by Donald Trump last week.
Belluscura said it was "currently assessing the potential financial implications, risks and opportunities of the imposition of tariffs", in particular the 54% tariff for goods imported from China, in which "a significant proportion" of its portable oxygen concentrators, raw materials and component parts were currently manufactured.

"In the light of the above, the company withdraws its previous market guidance for the current year ending 31 December 2025," said the AIM-listed group. "The company expects to make a further announcement once it has been able to better assess the situation, including possible subsequent developments."

As of 0925 BST, Belluscura shares had sunk 40% to 0.75p.









Reporting by Iain Gilbert at Sharecast.com

Email this article to a friend

or share it with one of these popular networks:

• DIGG
• FACEBOOK
• STUMBLEUPON
• MIXX
• YAHOO BUZZ
• DELICIOUS
• REDDIT
• NEWSVINE